Sierra Oncology, Inc.·4

Mar 14, 4:40 PM ET

Thomson Mary Christina 4

4 · Sierra Oncology, Inc. · Filed Mar 14, 2022

Insider Transaction Report

Form 4
Period: 2022-03-14
Thomson Mary Christina
General Counsel, CCO & Sec'y
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-14+35,00035,000 total
    Exercise: $31.54Exp: 2032-03-14Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the total shares subject to the option on March 14, 2023, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 14, 2026, subject to Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION